$0.1799
0.01448.7%
Last update: Nov 2, 10:20 AM
Kala Bio Inc (KALA) Stock Price, Quote, News & History
KALANASDAQ
FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.
You can purchase shares of Kala Bio (NASDAQ:KALA) through any online brokerage.
Other companies in Kala Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kala Bio has a consensus price target of $1300.00.
The stock price for Kala Bio (NASDAQ: KALA) is $0.179899 last updated November 2, 2026 at 10:20 AM EST.
There are no upcoming dividends for Kala Bio.
Kala Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Kala Bio.
Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a...
